YorkBridge Wealth Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-704
Closed -$92K 725
2019
Q2
$92K Buy
704
+8
+1% +$1.03K 0.04% 300
2019
Q1
$94K Buy
696
+93
+15% +$11.6K 0.04% 288
2018
Q4
$59K Sell
603
-111
-16% -$13.1K 0.03% 316
2018
Q3
$98K Sell
714
-792
-53% -$99.3K 0.04% 288
2018
Q2
$187K Hold
1,506
0.08% 182
2018
Q1
$168K Buy
1,506
+31
+2% +$3.71K 0.08% 201
2017
Q4
$166K Buy
1,475
+84
+6% +$10.2K 0.08% 199
2017
Q3
$195K Sell
1,391
-34
-2% -$4.62K 0.1% 176
2017
Q2
$173K Buy
1,425
+982
+222% +$114K 0.09% 187
2017
Q1
$59K Buy
443
+20
+5% +$2.58K 0.03% 353
2016
Q4
$50K Buy
+423
New +$51.8K 0.03% 353

Other funds holding ALXN